Press "Enter" to skip to content

Johnson & Johnson to submit applications for at least 10 new drugs by 2023

This is part of the healthcare conglomerate’s plan to deliver above-market growth through 2023 at its Janssen unit, it said.

Original source:

Also Read:   Oklahoma judge reduces Johnson & Johnson opioid payout to $465 million